Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clinicians know what patients want?

Maxime J M van der Valk,Marit E van der Sande,Renee E Toebes,Stephanie O Breukink,Mirelle E E Bröker,Pascal G Doornebosch,Nansi Maliko,Peter A Neijenhuis,Andreas W K S Marinelli,Femke P Peters,Koen C M J Peeters,Geerard L Beets,Perla J Marang-van de Mheen,Denise E Hilling,Maxime J.M. van der Valk,Marit E. van der Sande,Renee E. Toebes,Stephanie O. Breukink,Mirelle E.E. Bröker,Pascal G. Doornebosch,Peter A. Neijenhuis,Andreas W.K.S. Marinelli,Femke P. Peters,Koen C.M.J. Peeters,Geerard L. Beets,Perla J. Marang-van de Mheen,Denise E. Hilling

DOI: https://doi.org/10.1016/j.ejso.2020.04.014

IF: 4.037

2020-09-01

European Journal of Surgical Oncology

Abstract:IntroductionSeveral factors are included in decision making for treatment of patients with locally advanced rectal cancer, including a trade-off between risks and gains of both clinical and functional outcomes. However, it is largely unknown which outcomes are most important to patients and whether this differs between patients and clinicians.MethodsBoth clinicians and patients treated for locally advanced rectal cancer were invited to fill out an online questionnaire, including a choice-based conjoint experiment. Participants were presented 14 comparisons of two hypothetical case presentations, characterized by different treatments and outcomes of care (6 attributes) and were asked to select the case with the best outcome at that moment. Hierarchical Bayes Estimation was used to calculate the relative importance (RI) of each of the six attributes.ResultsIn total, 94 patients and 128 clinicians completed the questionnaire. For patients, avoiding surgery with permanent stoma was most important (RI 24.4, 95%CI 21.88–26.87) and a 2-year difference in disease-free survival was least important (RI 5.6, 95%CI 4.9–6.2%). Clinicians assigned highest importance to avoiding severe and daily worries about cancer recurrence (RI 30.7, 95%CI 29.1–32.4), while this was ranked 4th by patients (RI 17.9, 95%CI 16.5–19.4, p < 0.001).ConclusionWhen confronted with different outcomes within one case description, patients find the duration of disease free survival the least important. In addition, considerable differences were found between the importance assigned by patients and clinicians to clinical and functional outcomes, most notably in avoiding surgery with permanent stoma and worries about recurrence.

What problem does this paper attempt to address?

### Problems the paper attempts to solve

This paper aims to explore the importance perception of different clinical and patient - reported outcomes by patients with locally advanced rectal cancer and their treating physicians. Specifically, the study attempts to answer the following questions:

1. **Which treatment outcomes do patients value the most?**
When faced with different treatment options, which outcomes do patients care about the most? For example, avoiding permanent stoma surgery, no fecal incontinence, no urinary incontinence, no sexual dysfunction, no worry about cancer recurrence, etc.

2. **Is the importance that physicians attach to these outcomes consistent with that of patients?**
Which outcomes do physicians consider the most important during the decision - making process? Are their views consistent with the actual needs and preferences of patients?

3. **Are there preference differences among patients with different treatment paths?**
Among patients receiving different treatments (such as surgery, watch and wait, etc.), are there significant differences in the importance they attach to various outcomes?

### Research background

The standard treatment for rectal cancer usually includes preoperative chemoradiotherapy and surgery. Although the local recurrence rate and survival rate have improved significantly in recent years, the treatment is still accompanied by a relatively high morbidity, including temporary or permanent colostomy, fecal incontinence, urinary incontinence and sexual dysfunction. For patients without residual tumors after neoadjuvant chemoradiotherapy, the "clinical complete response" (cCR) and "watch and wait" (W&W) strategies are gradually being adopted to avoid the risks associated with surgery. However, whether this strategy meets the preferences and needs of patients remains a question to be explored.

### Research methods

The study collected data through questionnaires and choice - based conjoint experiments. The participants included patients with locally advanced rectal cancer and physicians directly involved in treatment decision - making. The questionnaire was divided into three parts:

1. **General information**: Collect basic information such as the age, gender, and occupation of the participants.
2. **Direct ranking exercise**: Require participants to rank the importance of seven treatment outcomes.
3. **Choice experiment**: Participants need to select the treatment outcome they consider the best in 14 hypothetical cases. Each case is described by six attributes, and each attribute has multiple levels.

### Main findings

- **Outcomes most valued by patients**: Avoiding permanent stoma surgery (relative importance RI 24.4, 95% CI 21.88 - 26.87), while the difference in 2 - year disease - free survival was considered the least important (RI 5.6, 95% CI 4.9 - 6.2).
- **Outcomes most valued by physicians**: Avoiding severe daily worry about cancer recurrence (RI 30.7, 95% CI 29.1 - 32.4), while patients attach less importance to this (RI 17.9, 95% CI 16.5 - 19.4).
- **Differences between patients and physicians**: There are significant differences in the importance that patients and physicians attach to certain outcomes, especially in terms of avoiding permanent stoma surgery and worry about cancer recurrence.

### Conclusion

When patients are faced with multiple treatment outcomes, they are more concerned about functional outcomes rather than an extra one or two years of disease - free survival. In addition, there are significant differences between patients and physicians in the importance of clinical and functional outcomes, especially in terms of views on avoiding permanent stoma surgery and worry about cancer recurrence. Therefore, it is very important to fully understand the preferences and needs of patients when formulating individualized treatment plans.